Rare genetic disorder gives clues to autism, epilepsy, mental retardationSeptember 24, 2008Symptoms may stem from structural abnormalities in neurons that lead to excess brain connections A rare genetic disorder called tuberous sclerosis complex (TSC) is yielding insight into a possible cause of some neurodevelopmental disorders: structural abnormalities in neurons, or brain cells. Researchers in the F.M. Kirby Neurobiology Center at Children's Hospital Boston, led by Mustafa Sahin, MD, PhD, and Xi He, PhD, also found that normal neuronal structure can potentially be restored. If this could be done safely in humans, it might be possible to ameliorate the symptoms of epilepsy, mental retardation and autism, which are frequent complications of TSC, say the researchers. Their findings, accompanied by commentary, were the cover article of the September 15 issue of Genes & Development.
TSC causes benign tumor-like lesions, which can affect every organ in the body and are called tubers when they occur in the brain. In the study, Sahin, He, lead author Yong-Jin Choi, PhD, and colleagues show in mice that when the two genes linked to the disease, TSC1 and TSC2, are inactivated, neurons grow too many axons (the long nerve fibers that transmit signals). Normal neurons grow just one axon and multiple dendrites (short projections that receive input from other neurons). This specification of axons and dendrites, known as polarity, is crucial for proper information flow. "We think if initial polarity is not formed properly, the result will be abnormal connectivity in the brain," says Sahin, who also directs the clinical Multi-Disciplinary Tuberous Sclerosis program at Children's. Since autism occurs in about half of people with TSC, the findings support the idea that such miswiring causes or contributes to autism, Sahin adds. He has received funding from Autism Speaks, the Manton Foundation and the Tuberous Sclerosis Alliance to pursue this idea further. "People have started to look at autism as a developmental disconnection syndrome - there are either too many connections or too few connections between different parts of the brain," Sahin says. "In mouse models of TSC, we're seeing an exuberance of connections." In laboratory experiments, the researchers were able to limit multiple axon formation by using the cancer drug rapamycin to suppress production of a protein called SAD-A kinase. This protein is produced in excess when the TSC1 and TSC2 genes are inactivated, and is found in abundance in the abnormally large cells that make up tubers. Because increased SAD-A is associated with increased axon growth, the researchers also speculate that the TSC pathway could be manipulated to regenerate or repair axons lost or damaged in spinal cord or other nerve injuries. "These findings provide a potential explanation for neurological abnormalities in TSC patients and perhaps in people without TSC," says He. "The challenge remains as to how to treat these conditions. We have some clues but a lot more research needs to be done." Children's Hospital Boston | |||||||||||||||||||||
|
Related Tuberous Sclerosis Current Events and Tuberous Sclerosis News Articles The first autism disease genes The autistic disorder was first described, more than sixty years ago, by Dr. Leo Kanner of the Johns Hopkins Hospital (USA), who created the new label 'early infantile autism'. Drug reverses mental retardation caused by genetic disorder UCLA researchers discovered that an FDA-approved drug reverses the brain dysfunction inflicted by a genetic disease called tuberous sclerosis complex (TSC). Genetic breakthrough offers promise in tackling kidney tumors A new study has shown promising results in fighting a severe genetic disorder which can create tumours throughout the body. Transplant drug sirolimus shrinks tumors, improves lung function The drug sirolimus, normally used to help transplant patients fight organ rejection, may eventually be used as a less invasive treatment for a tumor called angiomyolipomata in patients with who would otherwise face surgery. Pathway links inflammation, angiogenesis and breast cancer A well-known inflammatory protein spawns an enzyme that inactivates two tumor-suppressing genes, ultimately triggering production of new blood vessels to nourish breast cancer cells. Researchers make progress against lung disease attacking women in childbearing years Researchers are advancing against a rare, deadly lung disease (related to hormones) that no one had even heard of a decade ago. The disease targets only women, striking them down during their childbearing years. Bold Three-Stage Brain Operation for Intractable Seizures Appears Promising Sadly, none of the treatments for epilepsy-anti-seizure medications, a procedure called vagus nerve stimulation, a special diet -could quell the electrical storms in the young boy's brain. Tiny RNA molecules fine-tune the brain's synapses Non-coding regions of the genome - those that don't code for proteins - are now known to include important elements that regulate gene activity. Harmful chemicals may reprogram gene response to estrogen New research shows that exposure to harmful chemicals and drugs during critical developmental periods early in life may actually "reprogram" the way certain genes respond to the female hormone estrogen. This genetic reprogramming may determine whether people with a genetic predisposition for a disease actually develop the disease. More Tuberous Sclerosis Current Events and Tuberous Sclerosis News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||